首页 | 本学科首页   官方微博 | 高级检索  
     

恶性血液病自体造血干细胞移植治疗的疗效分析
引用本文:廖建军,薛重重,杨丽萍,黄继贤,韦湘,谢治军. 恶性血液病自体造血干细胞移植治疗的疗效分析[J]. 中国医药科学, 2012, 0(14): 28+32
作者姓名:廖建军  薛重重  杨丽萍  黄继贤  韦湘  谢治军
作者单位:汕头大学医学院附属粤北人民医院血液内科
摘    要:目的评价自体造血干细胞移植治疗恶性血液病患者的疗效。方法将60例恶性血液病患者分成观察组和对照组。对照组采用单纯化疗治疗,观察组采用自体造血干细胞移植治疗。结果观察组存活率73.33%高于对照组46.67%,差异有统计学意义(P<0.05)。结论自体造血干细胞移植治疗恶性血液病患者相关死亡率低,生存率较高,可作为恶性血液病治疗的重要方法。

关 键 词:自体造血干细胞移植  恶性血液病  化疗

Analysis of therapeutic effect on autologous hematopoietic stem cell transplantation
LIAO Jianjun,XUE Zhongzhong,YANG Liping,HUANG Jixian,WEI Xiang,XIE Zhijun. Analysis of therapeutic effect on autologous hematopoietic stem cell transplantation[J]. China Medicine and Pharmacy, 2012, 0(14): 28+32
Authors:LIAO Jianjun  XUE Zhongzhong  YANG Liping  HUANG Jixian  WEI Xiang  XIE Zhijun
Affiliation:Yuebei People’s Hospital Affiliated Shantou University of Medical College,Shaoguan 512026,China
Abstract:Objective To evaluate the efficacy of AHSCT treatment of malignant hematological disease. Methods In 60 patients with malignant hematologic diseases,divided into the observation group and the control group.Treating the control group with chemotherapy alone.The observation group was given AHSCT treatment. Results The survival rate of the observation group was 73.33%,which was higher than 46.67% of the control group. The difference was statistically significant (P < 0.05). Conclusion AHSCT in the treatment of patients with malignant blood disease,low mortality rate,survival rate is high,which can be used as an important method of treatment of hematologic malignancies.
Keywords:AHSCT  Malignant hematological disease  Chemotherapy
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号